Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methicillin-resistant Staphylococcus aureus: pediatric perspective.

M W Kline1, E O Mason

  • 1Division of Infectious Diseases, St. Louis University School of Medicine, Missouri.

Pediatric Clinics of North America
|June 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staphylococcus aureus infections among children receiving a solid organ transplant: clinical features, epidemiology, and antimicrobial susceptibility.

Transplant infectious disease : an official journal of the Transplantation Society·2015
Same author

Effectiveness of a training program to increase the capacity of health care providers to provide HIV/AIDS care and treatment in Swaziland.

AIDS care·2009
Same author

Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation.

Vaccine·2001
Same author

Failure of the conjugate pneumococcal vaccine to prevent recurrent bacteremia in a child with human immunodeficiency virus disease.

The Pediatric infectious disease journal·2001
Same author

Invasive pneumococcal infections in pediatric cardiac transplant patients.

The Pediatric infectious disease journal·2001
Same author

Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection.

The Pediatric infectious disease journal·2001
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Methicillin-resistant Staphylococcus aureus (MRSA) is a significant hospital-acquired infection in children, often requiring vancomycin treatment. Effective infection control remains challenging, highlighting MRSA

Area of Science:

  • Infectious Diseases
  • Pediatric Medicine
  • Microbiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a critical nosocomial pathogen in pediatric populations.
  • Infections primarily affect hospitalized children with predisposing medical conditions.
  • MRSA can infect any body site, frequently leading to concurrent bacteremia.

Purpose of the Study:

  • To highlight the clinical significance of MRSA in pediatric patients.
  • To discuss treatment challenges and outcomes associated with MRSA infections in children.
  • To underscore the importance of infection control measures.

Main Methods:

  • Review of clinical significance and treatment of MRSA in pediatric patients.
  • Analysis of factors influencing adverse outcomes.

Related Experiment Videos

  • Evaluation of the efficacy of infection control strategies.

    • Main Results:

    • Vancomycin is the recommended treatment for severe MRSA infections; other antibiotics like PRPs and cephalosporins are generally ineffective.
    • Adverse outcomes correlate with the severity of underlying conditions and delayed treatment.
    • Current infection control measures show limited success in hospital-wide MRSA eradication.

    Conclusions:

    • MRSA poses a persistent and significant clinical challenge in pediatric care.
    • Prompt and appropriate therapy is crucial for improving patient outcomes.
    • Continued vigilance and improved infection control strategies are necessary.